Generic placeholder image

Current Women`s Health Reviews

Author(s): Tayebeh Jahed Bozorgan, Samira Dehghani*, Atefeh Mahmoodi and Reza Hosseiniara

DOI: 10.2174/1573404819666221125095418

DownloadDownload PDF Flyer Cite As
Comparison of the Effect of Oral Sodium Bicarbonate and Tolterodine in Women with Symptoms of Overactive Bladder with Acidic Urine- A Single-Blind Randomized Clinical Trial

Article ID: e251122211237 Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: Urine alkalinization with oral sodium bicarbonate seems to improve urinary symptoms in female patients with overactive bladder with acidic urinary pH.

Aim: Therefore, the aim of this study was to compare the effect of oral sodium bicarbonate and tolterodine in women with symptoms of overactive bladder with acidic urinary pH.

Methods: In this single-blind randomized clinical trial, 72 female patients with symptoms of overactive bladder syndrome with acidic urinary pH in the age group of 28-60 years were referred to the gynecology clinic of Mahdieh Hospital affiliated with Shahid Beheshti University of Medical Sciences, Tehran, Iran in 2021-2022 were studied. These patients were randomly divided into two groups oral sodium bicarbonate (36 patients) and tolterodine group (36 patients) and received the treatment for one month. Group matching was performed between patients. At the end of the study, the Overactive Bladder- Validated 8-question Awareness tool (OAB-V8), frequency, nocturia, urgency, and urinary incontinence (UI) was measured and compared between patients in the two groups.

Results: Patients were matched for age, underlying disease, BMI, acidic urinary pH, and menopause status at the baseline. After 30 days of medication therapy, a significant decrease in OAB-V8 score, frequency, nocturia, urgency, and urinary incontinence (UI) was observed in both groups receiving oral sodium bicarbonate and tolterodine in female patients with symptoms of overactive bladder syndrome with acidic urine. The degree of improvement in outcomes after treatment was similar between both groups.

Conclusion: Oral sodium bicarbonate administration in patients with overactive bladder with acidic urinary pH has a significant positive effect on OAB-V8 symptoms, frequency, nocturia, urgency, and urinary incontinence (UI) and these results are similar to tolterodine treatment. Given that the acidic urinary pH may play a role in the etiology of an overactive bladder, it seems that sodium bicarbonate improves the symptoms of an overactive bladder by alkalizing the urine.

Graphical Abstract

[1]
Joseph, S.; Maria, S.A.; Peedicayil, J. Drugs currently undergoing preclinical or clinical trials for the treatment of overactive bladder: a review. Curr. Ther. Res. Clin. Exp., 2022, 96, 100669.
[http://dx.doi.org/10.1016/j.curtheres.2022.100669] [PMID: 35494662]
[2]
Baghi, I.; Malekshahi, A.; Mobayen, M.; Mousavi, M. Evaluation of diagnostic value of FAST in patients with multiple trauma referring to a trauma center in northern Iran. Novelty. Clin. Med., 2022, 1(3), 135-142.
[http://dx.doi.org/10.22034/ncm.2022.336374.1033]
[3]
Stewart, W.; Van Rooyen, J.; Cundiff, G.; Abrams, P.; Herzog, A.; Corey, R.; Hunt, T.; Wein, A. Prevalence and burden of overactive bladder in the United States. World J. Urol., 2003, 20(6), 327-336.
[http://dx.doi.org/10.1007/s00345-002-0301-4] [PMID: 12811491]
[4]
Milsom, I.; Abrams, P.; Cardozo, L.; Roberts, R.G.; Thüroff, J.; Wein, A.J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int., 2001, 87(9), 760-766.
[http://dx.doi.org/10.1046/j.1464-410x.2001.02228.x] [PMID: 11412210]
[5]
Gormley, E.A.; Lightner, D.J.; Faraday, M.; Vasavada, S.P. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J. Urol., 2015, 193(5), 1572-1580.
[http://dx.doi.org/10.1016/j.juro.2015.01.087] [PMID: 25623739]
[6]
Hashim, H.; Abrams, P. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations. Drugs, 2004, 64(15), 1643-1656.
[http://dx.doi.org/10.2165/00003495-200464150-00003] [PMID: 15257626]
[7]
Andersson, K.E.; Wein, A.J. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol. Rev., 2004, 56(4), 581-631.
[http://dx.doi.org/10.1124/pr.56.4.4] [PMID: 15602011]
[8]
Andersson, K.E. Antimuscarinics for treatment of overactive bladder. Lancet Neurol., 2004, 3(1), 46-53.
[http://dx.doi.org/10.1016/S1474-4422(03)00622-7] [PMID: 14693111]
[9]
Hartmann, K.E.; McPheeters, M.L.; Biller, D.H.; Ward, R.M.; McKoy, J.N.; Jerome, R.N.; Micucci, S.R.; Meints, L.; Fisher, J.A.; Scott, T.A.; Slaughter, J.C. Treatment of overactive bladder in women. Database of Abstracts of Reviews of Effects (DARE); Quality-assessed Reviews, 2009.
[10]
Raju, R.; Linder, B.J. Evaluation and treatment of overactive bladder in women. Mayo Clin. Proceedings, 2020, 95(2), 370-377.
[http://dx.doi.org/10.1016/j.mayocp.2019.11.024]
[11]
Sönmez, M.G.; Göğer, Y.E.; Ecer, G.; Atıcı, A.; Özkent, M.S.; Öztürk, A. Effects of urine alkalinization with sodium bicarbonate orally on lower urinary tract symptoms in female patients: a pilot study. Int. Urogynecol. J. Pelvic Floor Dysfunct., 2018, 29(7), 1029-1033.
[http://dx.doi.org/10.1007/s00192-017-3492-3] [PMID: 28975365]
[12]
Sönmez, M.G.; Ecer, G.; Atici, A.; Özkent, M.S.; İyisoy, M.S.; Öztürk, A. Comparison of oral sodium bicarbonate and solifenacin treatment in female overactive bladder patients with acidic urine pH. Female Pelvic Med. Reconstr. Surg., 2020, 26(10), 649-653.
[http://dx.doi.org/10.1097/SPV.0000000000000642] [PMID: 30335650]
[13]
Olivera, C.K.; Meriwether, K.; El-Nashar, S.; Grimes, C.L.; Chen, C.C.G.; Orejuela, F.; Antosh, D.; Gleason, J.; Kim-Fine, S.; Wheeler, T.; McFadden, B.; Balk, E.M.; Murphy, M. Nonantimuscarinic treatment for overactive bladder: A systematic review. Am. J. Obstet. Gynecol., 2016, 215(1), 34-57.
[http://dx.doi.org/10.1016/j.ajog.2016.01.156] [PMID: 26851599]
[14]
Rogers, R.; Bachmann, G.; Jumadilova, Z.; Sun, F.; Morrow, J.D.; Guan, Z.; Bavendam, T. Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. Int. Urogynecol. J. Pelvic Floor Dysfunct., 2008, 19(11), 1551-1557.
[http://dx.doi.org/10.1007/s00192-008-0688-6] [PMID: 18685795]
[15]
Kahle, L.E.; Kelly, P.V.; Eliot, K.A.; Weiss, E.P. Acute sodium bicarbonate loading has negligible effects on resting and exercise blood pressure but causes gastrointestinal distress. Nutr. Res., 2013, 33(6), 479-486.
[http://dx.doi.org/10.1016/j.nutres.2013.04.009] [PMID: 23746564]
[16]
Demirbas, A.; Sarici, H.; Kilinc, M.F.; Telli, O.; Ozgur, B.C.; Doluoglu, O.G.; Bozkurt, S. The relationship between acidic urinary pH and overactive bladder; alkalization of urine improves the symptoms of overactive bladder. Urol. Int., 2015, 95(2), 223-226.
[http://dx.doi.org/10.1159/000375322] [PMID: 25766740]
[17]
Brumfitt, W.; Hamilton-Miller, J.M.; Cooper, J.; Raeburn, A. Relationship of urinary pH to symptoms of ‘cystitis’. Postgrad. Med. J., 1990, 66(779), 727-729.
[http://dx.doi.org/10.1136/pgmj.66.779.727] [PMID: 2235803]
[18]
Cohen, B.; Laish, I.; Brosh-Nissimov, T.; Hoffman, A.; Katz, L.H.; Braunstein, R.; Sagi, R.; Michael, G. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial. Am. J. Emerg. Med., 2013, 31(12), 1703-1706.
[http://dx.doi.org/10.1016/j.ajem.2013.08.031] [PMID: 24055481]
[19]
Nalliah, S.; Wg, P.; Masten Singh, P.K.; Naidu, P.; Lim, V.; Ahamed, A.A. Comparison of efficacy and tolerability of pharmacological treatment for the overactive bladder in women: A network meta-analysis. Aust. Fam. Physician, 2017, 46(3), 139-144.
[PMID: 28260277]
[20]
Margolis, M.K.; Vats, V.; Coyne, K.S.; Kelleher, C. Establishing the content validity of the King’s Health Questionnaire in men and women with overactive bladder in the US. Patient, 2011, 4(3), 177-187.
[http://dx.doi.org/10.2165/11586480-000000000-00000] [PMID: 21766913]